Review, 2003
What is PMDD and what treats it?
PMDD is a severe form of PMS affecting 3-8% of women of reproductive age. It is marked by depression, anxiety, emotional instability, and reduced activity during the luteal phase. SSRIs (selective serotonin reuptake inhibitors) are the most effective treatment.
What they did
Literature review of PMDD definition, prevalence, causes, and treatment options.
What they found
PMDD affects 3-8% of women. Key symptoms are depressive mood, marked anxiety, emotional instability, and decreased activity that appear in the luteal phase and stop in the follicular phase. Serotonin and melatonin metabolism play a role. SSRIs are most effective.
What it means for you
PMDD is a real, treatable condition affecting a significant portion of women in their reproductive years. This summarizes current medical understanding rather than presenting new research.
3-8%
Women of reproductive age with PMDD
About the study
- Original title
- [Premenstrual dysphoric disorder: approach and treatment]
- Authors
- Bianchi-Demicheli F, Lüdicke F, Campana A
- Journal
- Gynecologie, obstetrique & fertilite
- Year
- 2003
- Study design
- Review
- What was tested
- None - review of treatment approaches
- Read the paper
- doi.org/10.1016/s1297-9589(02)00007-3
Topics
Related studies
Randomised trial, 1995
Does fluoxetine help premenstrual dysphoria?
Study, 2026
Do anxiety and depression get worse before your period if you already have a mental health condition?
Review, 2023
Can herbs and supplements help with PMS symptoms?
Randomised trial, 2017
Does Sepranolone reduce symptoms of severe premenstrual syndrome (PMDD)?
Cohort study, 2012
How quickly does fluoxetine start working for PMDD symptoms?
Review, 1999
Is premenstrual dysphoric disorder a distinct clinical disorder?